维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

16篇 您的检索式：期刊名="Invest NewDrugs"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinoma显示文摘	Ko AH Youssoufian H Gurtler J	2012	Invest NewDrugs2012，30，4：	1
	2	The Wnt-dependent signalingpathways as target in oncology drug discovery 显示文摘	Janssens N Janicot M Perera T	2006	Invest NewDrugs2006，24，4：	1
	3	A clinical screen-ing cooperative group phase U evaluation of lobaplatin( ASTA D-19466) in advanced head and neck cancer 显示文摘	Deganlin M Armand JP Chevallier B	1995	Invest NewDrugs1995，13，3：	1
	4	Phase II study of sunitinib assecond-line treatment for advanced gastric cancer显示文摘	Bang YJTKang YK Kang WK	2011	Invest NewDrugs2011，29，6：	1
	5	Gemcitabine innon-small cell lung cancer (NSCLC)显示文摘	Zatloukal P Krejcy K	2000	Invest NewDrugs2000，18，1：	1
	6	Recent advances in brain tumor therapy: local intracerebral drug delivery by polymers显示文摘	Olivi A Weingart JD	2004	Invest NewDrugs2004，22，1：	1
	7	Phase H study of sunitinib assecond-line treatment for advanced gastric cancer 显示文摘	Bang YJ Kang YK Kang WK	2011	Invest NewDrugs2011，29，6：	1
	8	Cytotoxic effectsof curcumin on osteosarcoma cell lines显示文摘	Walters DK Muff R Langsam B	2008	Invest NewDrugs2008，26，4：	1
	9	Sorafenib in patients withmetastatic gastrointestinal stromal tumors who failed two ormore prior tyrosine kinase inhibitors: a phase II study of Kore-an gastrointestinal stromal tumors study group 显示文摘	Park SH Ryu MH Ryoo BY	2012	Invest NewDrugs2012，30，6：	1
	10	Phase I dose-finding study of so-rafenib in combination with capecitabine and cisplatin as a first-linetreatment in patients with advanced gastric cancer 显示文摘	Kim C Lee JL Choi YH	2012	Invest NewDrugs2012，30，1：	1
	11	Phase lltrail ofcapecitabine and everolimus (RAD001) combination in refractory gastric cancer patients 显示文摘	Lee SJ Lee J Lee J etal	2013	Invest NewDrugs2013，31，6：	1
	12	Amrubicin for non-small-cell lung cancer and small-cell lung cancer 显示文摘	Kurata T Okamoto I Tamura K	2007	Invest NewDrugs2007，25，5：	1
	13	Phase Idose- finding and pharmacokinetic trial of orally administered in-dibulin ( D-24851 ) to patients with solid tumors 显示文摘	KUPPENS I E WITTEVEEN P 0 SCHOT M	2007	Invest NewDrugs2007，25，3：	1
	14	Phase II trail of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients 显示文摘	Lee SJ Lee J Lee J	2013	Invest NewDrugs2013，31，6：	1
	15	Growth inhibition induced by antiprogestins RU-38486,ORG-31710,and CDB-2914in ovarian cancer cells involves inhibition of cyclin dependent kinase2显示文摘	Goyeneche AA Seidel EE Telleria CM	2012	Invest NewDrugs2012，30，3：	1
	16	Pyridoxine therapy for pal2 marplantar erythrodysesthesia associated with cntinuous 5 -flu2 orouracilinfusion显示文摘	Molina R Slavik M	1990	Invest NewDrugs1990，8，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费